Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 7760, October 1, 2008. doi: 10.1158/0008-5472.CAN-08-0020
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Milicic, A.
Right arrow Articles by Jankowski, J. A.Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milicic, A.
Right arrow Articles by Jankowski, J. A.Z.

Cell, Tumor, and Stem Cell Biology

Ectopic Expression of P-Cadherin Correlates with Promoter Hypomethylation Early in Colorectal Carcinogenesis and Enhanced Intestinal Crypt Fission In vivo

Anita Milicic1, Lea-Anne Harrison2, Robert A. Goodlad4, Robert G. Hardy7, Anna M. Nicholson1, Michal Presz1, Oliver Sieber5, Sonia Santander8, James H. Pringle3, Nikki Mandir4, Philip East6, Jolanta Obszynska2, Scott Sanders2, Elena Piazuelo8, Jacqui Shaw3, Rebecca Harrison4, Ian P. Tomlinson5, Stuart A.C. McDonald1,2,4, Nicholas A. Wright4 and Janusz A.Z. Jankowski1,2,4

1 Department of Clinical Pharmacology, University of Oxford, Oxford, United Kingdom; 2 Digestive Diseases Centre and 3 Department of Cancer Studies and Molecular Medicine, Leicester Royal Infirmary, University of Leicester, Leicester, United Kingdom; 4 Histopathology Unit, 5 Molecular and Population Genetics, and 6 Bioinformatics and Biostatistics, Cancer Research UK, London Research Institute, London, United Kingdom; 7 Department of Surgery, Royal Infirmary, University of Edinburgh, Edinburgh, United Kingdom; and 8 Instituto Aragones de Ciencias de la Salud, CIBERehd, Zaragoza, Spain

Requests for reprints: Janusz Jankowski, Digestive Diseases Center, 4th floor Windsor Building, Leicester Royal Infirmary, Leicester, LE1 5WW, England, United Kingdom. Phone: 44-116-2047850; Fax: 44-1865-616022; E-mail: janusz.jankowski{at}uhl-tr.nhs.uk.

Key Words: colorectal cancer • P-cadherin • stem cells • hypomethylation • crypt bifurcation

P-cadherin is normally expressed in the basal layer of squamous epithelia and absent from the healthy intestine and colon. We have previously shown it to be expressed in all inflamed, hyperplastic, and dysplastic intestinal and colonic mucosa. This study aimed to better understand the mechanisms controlling the expression of P-cadherin and the biological effects of its ectopic presence in the intestine and colon. We investigated the CpG methylation status of the P-cadherin (CDH3) promoter and P-cadherin mRNA and protein expression in cases of familial and sporadic colorectal cancer (CRC). The CDH3 promoter was hypomethylated in colonic aberrant crypt foci, in CRC, and, occasionally, in the normal epithelium adjacent to cancer, demonstrating a potential "field effect" of cancerization. The hypomethylation was also associated with induction of P-cadherin expression in the neoplastic colon (P < 0.0001). We then created transgenic mice that overexpressed P-cadherin specifically in the intestinal and colonic epithelium under the liver fatty acid binding protein promoter. Forced ectopic expression of P-cadherin accompanied by indomethacin-induced inflammation resulted in a 3-fold higher crypt fission rate within the small and large intestines in the homozygous mice compared with the wild-type animals (P < 0.02). We conclude that epigenetic demethylation of the P-cadherin promoter in the human intestine permits its ectopic expression very early in the colorectal adenoma-carcinoma sequence and persists during invasive cancer. Induced P-cadherin expression, especially in mucosal damage, leads to an increased rate of crypt fission, a common feature of clonal expansion in gastrointestinal dysplasia. [Cancer Res 2008;68(19):7760–8]




This article has been cited by other articles:


Home page
Anticancer ResHome page
K. HIBI, Y.-H. KITAMURA, H. MIZUKAMI, T. GOTO, K. SAKURABA, M. SAKATA, M. SAITO, K. ISHIBASHI, G. KIGAWA, H. NEMOTO, et al.
Frequent CDH3 Demethylation in Advanced Gastric Carcinoma
Anticancer Res, October 1, 2009; 29(10): 3945 - 3947.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
K. HIBI, T. GOTO, H. MIZUKAMI, Y.-H. KITAMURA, K. SAKURABA, M. SAKATA, M. SAITO, K. ISHIBASHI, G. KIGAWA, H. NEMOTO, et al.
Demethylation of the CDH3 Gene Is Frequently Detected in Advanced Colorectal Cancer
Anticancer Res, June 1, 2009; 29(6): 2215 - 2217.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
H. Chai and R. E. Brown
Field Effect in Cancer-An Update
Ann. Clin. Lab. Sci., January 1, 2009; 39(4): 331 - 337.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.